Real-World Safety and Efficacy of Pembrolizumab in Japanese Patients With Radically Unresectable Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Real-world safety and effectiveness of pembrolizumab in Japanese patients with radically unresectable melanoma: An all-case postmarketing surveillance in Japan
J Dermatol 2022 Jul 27;[EPub Ahead of Print], N Yamazaki, A Shimizu, M Ozaki, M Hamada, N Takeuchi, Y Ito, S MaekawaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.